Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Does interferon-gamma influence LDL transcytosis, the earliest stage of atherosclerosis?
EF 2020-21
Résumé
Every blood vessel in the body is lined by a layer of specialized cells known as the endothelium. The accumulation of low-density lipoprotein (LDL) cholesterol (i.e. the ""bad cholesterol"") underneath that endothelial lining is one of the key and earliest steps in the initiation of heart disease (atherosclerosis)^3. For LDL in the blood to accumulate under the endothelium, it must first cross the layer of endothelial cells through a process called transcytosis. However, the mechanisms of LDL transcytosis and how it is affected during disease remain largely unknown. The objective of the present study is to determine the effect of a well-known inflammatory protein, interferon gamma (IFN-γ) on LDL transcytosis. IFN-γ is a cytokine that can be detected in the earliest lesions of heart disease. Hence, we hypothesize that IFN-γ stimulates LDL transcytosis and accelerates atherosclerosis. To quantify LDL transcytosis in the presence of IFN-γ, a live cell imaging assay using total internal fluorescence microscopy was developed by our lab and will be performed using human endothelial cells. Next, western blot and immunofluorescence will be performed to assess the mechanism of any effect. To validate our findings from cells in culture, a mouse model for atherosclerosis will be used. Immunohistochemistry will be conducted to quantify and visualize the localization of LDL and mediators of LDL transcytosis under the influence of IFN-γ. Overall, this will allow us to better understand the pathophysiological basis of atherosclerosis and has the potential to reveal novel preventative and therapeutic approaches for atherosclerosis.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
449372
Name
Ho Tse Wing Winnie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Does interferon-gamma influence LDL transcytosis, the earliest stage of atherosclerosis?
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Activin Receptor-Like Kinase 1; Atherosclerosis; Cardiovascular Disease; Caveolin-1; Inflammation; Interferon Gamma; Low-Density Lipoproteins; Scavenger Receptor Class B Type 1; Total Internal Fluorescence Microscopy; Transcytosis
Abstract
Every blood vessel in the body is lined by a layer of specialized cells known as the endothelium. The accumulation of low-density lipoprotein (LDL) cholesterol (i.e. the ""bad cholesterol"") underneath that endothelial lining is one of the key and earliest steps in the initiation of heart disease (atherosclerosis)^3. For LDL in the blood to accumulate under the endothelium, it must first cross the layer of endothelial cells through a process called transcytosis. However, the mechanisms of LDL transcytosis and how it is affected during disease remain largely unknown. The objective of the present study is to determine the effect of a well-known inflammatory protein, interferon gamma (IFN-γ) on LDL transcytosis. IFN-γ is a cytokine that can be detected in the earliest lesions of heart disease. Hence, we hypothesize that IFN-γ stimulates LDL transcytosis and accelerates atherosclerosis. To quantify LDL transcytosis in the presence of IFN-γ, a live cell imaging assay using total internal fluorescence microscopy was developed by our lab and will be performed using human endothelial cells. Next, western blot and immunofluorescence will be performed to assess the mechanism of any effect. To validate our findings from cells in culture, a mouse model for atherosclerosis will be used. Immunohistochemistry will be conducted to quantify and visualize the localization of LDL and mediators of LDL transcytosis under the influence of IFN-γ. Overall, this will allow us to better understand the pathophysiological basis of atherosclerosis and has the potential to reveal novel preventative and therapeutic approaches for atherosclerosis.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ho, Tse Wing Winnie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~